2018-06-29

News from Sandberg Development: We have updated our privacy policy

On the 25th of May 2018 the new regulation in EU law on data protection and privacy for all individuals within the European Union, GDPR, was implemented. In connection with this we updated our privacy policy. Please see the complete policy below.

Privacy policy

The Processing of Personal Data

Our objective and intention is that you will be able to feel safe and secure when you provide your personal information to us at Sandberg Development AB. All processing of personal data is based on the provisions and requirements of the European Union’s General Data Protection Regulation (GDPR).

Data Controller

Sandberg Development AB is the data controller, pursuant to the GDPR, for the processing of personal data held by the company that takes place. Sandberg Development AB is responsible for the processing of personal data that takes place via our website www.sandbergdevelopment.com.

When does the processing of personal data occur?
Sandberg Development AB processes your personal information when you:

·      order publications

·      sign up for our newsletter subscription service, or other similar services,

·      look for an open position, register your interest in employment, or apply for employment with us,

·      otherwise seek contact with us

Data registered

When individuals place orders or make registrations, their name, address, telephone number and e-mail address are registered. When representatives of a company place orders or make registrations the name of the company’s contact persons, their position and the department they are from, well as their address, telephone number and e-mail address to the workplace, are registered. In other situations, the data you have chosen to provide is registered. Sandberg Development AB’s seeks to avoid registering civil identification numbers (social security numbers) and sensitive personal data such as racial or ethnic origin, political opinions, religious or philosophical beliefs, membership in trade unions, health matters and sex life. If you do provide such information, for example, prior to a seminar that you have a food allergy/intolerance and want or want to avoid certain foods, we presume that you want the information to be registered with us.

The purpose of the processing of personal data

When you ask for our courses and seminars, or order publications or newsletters via our website, by telephone or mail, you become a customer of ours. The personal information you provide is registered in our customer database and is used for the processing of providing the services and products that have been ordered. The information may also be used for marketing purposes as well as for follow-ups.

When you look for an open position with us, submit an expression of interest regarding employment with us, or apply, participate in surveys and provide information for “benchmarking” or tell us you want to be considered by us, we use your personal information only for the purpose for which you provided it.

Disclosure of personal data to others

With orders and registrations, the information recorded in the customer database may be disclosed to third parties, in other words to individuals or companies outside of Sandberg Development AB, to the extent necessary to be able to administer the participation in a course or seminar, or to process and fulfill the order. This also applies when you look for an open position, submit an expression of interest regarding employment, or apply for a job with us, participate in surveys and provide information for “benchmarking,” or tell us you want to be contacted by us. In all of the above-mentioned situations, Sandberg Development AB is the “data controller” responsible for the personal data and the contractors Sandberg Development AB uses are the “data processors”. The data processors are obligated to comply with Sandberg Development AB’s instructions and are not entitled to disclose your personal information to any other parties or to use them for any purposes other than those encompassed within Sandberg Development AB’s instructions. The data processors are also required to take certain technical and organizational measures to protect your personal data.

Finally, personal data may also be disclosed in the event this is required by law, regulation or a decision of a governmental authority.

How long is the information retained?

We retain the personal data for as long as necessary in order for us to be able to fulfill our commitments, i.e. provide the service, product or training, invoices, deal with complaints or claims, etc. If you have consented to that your contact information will remain in our customer database for marketing purposes even after the customer relationship has ended, it will remain in the database until you tell us that you want the information deleted.

Contact

If you have any questions concerning the processing of personal data within Sandberg Development AB, please contact us here

Registry extracts and corrections

You are entitled to obtain, once a year without cost, information about the personal data concerning you that is being processed by Sandberg Development AB. In such case, make your request in writing to the Data Protection Officer (for the address, see above). If in your opinion some information about you is incorrect or misleading, you can contact the Data Protection Officer and make a written request for a change.

Identification of Visitors– cookies and logs

Our website uses “cookies.” As you may know, “cookies” are small text files that are stored on your computer and among other uses, they are used to saving individualized settings and make it possible to monitor what visitors do on the website. There are two different types of “cookies.” One is “session cookies,” which are used during the time the visitor is active on the website. These cookies are only stored temporarily on the visitor’s computer, and are deleted automatically when the user closes their web browser. The other is “persistent cookies.” These are used to tell the visitor what happened on the website since they last visited the site, and to be able to identify returning users and remember the information provided previously. The initial settings for most browsers are set to accept cookies. However, if you do not want cookies to be stored in your computer, you can set your browser to notify you when it receives a cookie. At that point you can decide for yourself if you want to accept it or not. Sandberg Development AB prepares statistics relating to the number of visits and visitors, number of times each individual page is read, which URLs the visitor is coming from, and which search engines and keywords are used to reach our website. The purpose of all this is to give us an understanding of how we can improve our site and your experience as a customer. In this way we collect information about the domain name, web browser and operating system, the time when you entered our website and if you came via a link, what link. This information is not to be disclosed to third parties.

Security

There is always a risk involved with the submitting of personal information via the Internet. No technology system is completely protected from intrusion. However, Sandberg Development AB has taken all reasonable technical security measures that are required in order to protect personal data against unauthorized access, alteration or destruction.

Malmö, 25 May 2018

Martin Jonsson
President/CEO of Sandberg Development AB

All news

News from the Group: Camurus announces outcome of the arbitration process with Braeburn.

Camurus announced on December 10, 2020, that the ICC International Court of Arbitration has issued a partial award in the arbitration process between Camurus and Braeburn regarding the parties’ license agreement for the development and commercialization of CAM2038 in North America.

Read more

News from the Group: Camurus announces that Braeburn receives Complete Response Letter for Brixadi for opioid use disorder in the US

Camurus AB today announced that Camurus licensee Braeburn has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) regarding its new drug application (NDA) for Brixadi.

Read more

News from the Group: GAIM launches new website

GAIM launches their new website on the domain www.gaim.com

Read more

News from the Group: Camurus' Interim Report third quarter 2020

"Good performances were seen across markets and we are on track to deliver on our revenue guidance."

Read more

News from the Group: Another break-through order for ISEC

ISEC Monitoring Systems has received three substantial and strategically important orders during the last year, amounting to appr. 20 MSEK.

Read more

News from the Group: Camurus' Interim Report Second Quarter 2020

”For the fourth quarter in a row, we saw Buvidal® sales growth of more than 50%”

Read more

News from the Group: Camurus has completed a directed share issue

Camurus has completed a directed share issue of 2 million shares, raising proceeds of SEK 300 million.

Read more

News from the Group: Positive results from Phase 2 study

Positive results from Phase 2 study of once-weekly FluidCrystal® formulation of setmelanotide in healthy volunteers with obesity.

Read more

News from the Group: Camurus raises full year 2020 revenue guidance

The improvements are driven by increasing market shares of Buvidal® for treatment of opioid dependence in Europe and Australia.

Read more

News from the Group: Camurus Interim Report January-March 2020

”The number of patients treated with Buvidal® increased by 90 percent in the quarter”

Read more

News from the Group: Camurus Annual Report for 2019

Camurus Annual Report for 2019 is now available at the company´s website.

Read more

News from the Group: Camurus announces strong first quarter demand for Buvidal®

Camurus announced today continued strong revenue growth driven by increasing demand for weekly and monthly Buvidal® for the treatment of opiod dependence in EU and Australia.

Read more

News from the Group: Camurus' Full year report 2019

Camurus has published their Full year report 2019

Read more

News from the Group: Camurus has completed a directed share issue

The directed share issue (which was completed on December 6, 2019) of approximately 3,7 million shares will raise proceeds of approximately 300 MSEK.

Read more

News from the Group: GRANULDISK launches PowerGranules BIO

GRANULDISK has launched biodegradable granules, which eliminate the need for pre-washing, all while being kind to the environment.

Read more

News from the Group: Nytt från koncernen: Camurus’ treatment Buvidal® subsidised in Australia

Australia has announced that Camurus’ treatment Buvidal® (buprenorphine) will be listed through the Pharmaceutical Benefit Scheme (PBS).

Read more

News from the Group: Three new products from ISEC

ISEC has launched three new products for better and safer surveillance of radioactive environments.

Read more

News from the Group: Positive outcome for Camurus in court proceedings regarding final approval of Brixadi™ in the US

Camurus’ partner Braeburn have received a positive outcome in the US court proceedings which were initiated in April, 2019, regarding final approval for Brixadi (Buvidal® in the US) and the FDA is remanded to reconsider Braeburn’s application for final approval of Brixadi™ Monthly in the US.

Read more

News from the Group: FDA grants Camurus IND application to enter Phase 3 study with CAM2029 for treatment of acromegaly

The FDA has approved Camurus’ Investigational New Drug application to initiate a Phase 3 study with CAM2029 once-monthly octreotide subcutaneous depot for treatment of acromegaly.

Read more

News from Sandberg Development: Introducing the chemical-free office

Starting June 2019, all Sandberg Development's office and production facilities will be cleaned and washed with DIRO® water - completely without chemicals.

Read more

News from the Group: Court proceedings initiated for immediate market approval of Brixadi™ in the US

Camurus’ partner, Braeburn Inc., has initiated court proceedings foran approval of Brixadi (Buvidal® in the US) and to overturn the 3-year market exclusivity granted by the FDA to another product.

Read more

News from the Group: Positive results for Buvidal® in treatment for fentanyl dependence

New positive results from a Phase 3 study show that Camurus’ Buvidal® provides better treatment effect for fentanyl abuse, among other things, compared to other standard treatments as well as lower withdrawal and drug craving.

Read more

News from the Group: Camurus’ rights issue oversubscribed

Camurus’ rights issue of 403 MSEK has been oversubscribed. The rights issue was carried out to secure financing of the launch and marketing of Buvidal in Europe and Australia.

Read more

News from the Group: Aimpoint granted new large FCS contract from the U.S. Military

Aimpoint has been awarded a large contract of USD 24 million from the U.S. Military for the FCS13-RE system for SAAB’s portable weapon system Carl-Gustaf (MAAWS) and to be used by the U.S. Army, U.S. Marine Corps and the U.S. Special Operations Command.

Read more

News from the Group: Spin-off of GAIM from Aimpoint

Based on Aimpoint's red dot sight for fire arms, the company has developed a commercial VR platform, GAIM, which is now spun off to a separate company.

Read more

News from Sandberg Development: 60 years of driving innovation in Skåne

In 1959, Gunnar Sandberg established ElektroSandberg and lay the foundation for what we now know as Sandberg Development.

Read more

News from the Group: Camurus' Full year report 2018

Camurus' has published their Full year report 2018.

Read more

News from the Group: New CEO at GRANULDISK

As of January 7 Mikael Samuelsson is the new CEO for GRANULDISK.

Read more

News from the Group: Spin-off of Solo Rescue from GRANULDISK

During the summer it was decided to spin off operations focused on the decontamination of fire rescue equipment from GRANULDISK into a separate company - RESCUE Intellitech.

Read more

News from the group: New CEO at SWATAB

In November 2019 Mats Marklund took office as CEO for SWATAB.

Read more

News from the Group: Buvidal® Weekly and Buvidal® Monthly (CAM2038) approved in Australia as the first long-acting treatment of opioid dependence

Camurus announced today that the Australian Therapeutic Goods Administration (TGA) has approved the company’s lead products Buvidal® Weekly and Buvidal® Monthly (CAM2038) for maintenance treatment of opioid dependence within a framework of medical, social and psychosocial support.

Read more

News from the Group: Camurus receives EU approval for Buvidal®

Camurus receives EU approval for weekly and monthly Buvidal® (CAM2038) for opioid dependence. Buvidal® is the first long-acting medicine approved in the EU for the treatment of opioid dependence in adults and adolescents.

Read more

News from the Group: Camurus Interim Report January-September 2018

“Following the positive CHMP opinion for Buvidal®, we have ramped up our commercial activities and are ready for launch in the first wave European markets”, Fredrik Tiberg, President and CEO, says in his CEO comments.

Read more

News from the Group: AF Bostäder has installed SWATAB's filter system

AF Bostäder in Lund will open two new laundry rooms at Vildanden, a student housing, where the students can wash with super-clean water in a chemical-free process.

Read more

News from the Group: Spin-off of Solo Rescue from GRANULDISK

Sandberg Development has decided to spin-off and concentrate the business within the subsidiary GRANULDISK’s product area SOLO Rescue.

Read more

News from Sandberg Development: Sandberg Development invests in water technology company SWATAB

The family owned investment company Sandberg Development invests in SWATAB (SCANDINAVIAN WATER TECHNOLOGY AB). The investment implies a growth venture with an upscaling of the organization and production, which will be built in Sandberg Development’s premises in Malmö.

Read more

News from Sandberg Development: We have updated our privacy policy

On the 25th of May 2018 the new regulation in EU law on data protection and privacy for all individuals within the European Union, GDPR, was implemented. In connection with this we updated our privacy policy. Please see the complete policy below.

Read more

News from Sandberg Development: Sandberg Development invests in Orbital Systems

Sandberg Development invests SEK 30 million in the Malmö-based water recycling technology Company Orbital Systems.

Read more

News from Sandberg Development: Refurbishment of office facilities

In the beginning of November reconstruction work started at our office facilites at Jägershillgatan 15 in Malmö.

Read more

News from Sandberg Development: Sandberg Development invests in new development company

As part of our business concept - "Investing in innovations with growth in focus" - Sandberg Development has, during the summer, invested in an unlisted development Company, ISEC AB.

Read more

News from the Group: Camurus and Braeburn Pharmaceuticals announce positive Top-line results from long-term Phase 3 safety study of CAM2038

New data support long-term safety and efficacy of weekly and monthly subcutaneous buprenorphine depots in patients with opioid use disorder.

Read more

News from Sandberg Development: Acquisition of Scan Coin property

On April 18, 2017 the purchase deed was signed and Sandberg Development is now the owner of the property.

Read more

News from Sandberg Development: Refurbishment of production facilities complete

One year after the reconstruction work started, the new production facilities were completed in March 2017.

Read more

News from Sandberg Development: Refurbishment of production and office facilities

In March 2016 reconstruction and extension work started at our premises on Jägershillgatan 15 in Malmö. The first part of the reconstruction work involves the production facilities.

Read more

News from Sandberg Development: Sandberg Development sponsor of Star for Life

From 2015 Sandberg Development is a sponsor of Star for Life, an educational/motivational programme, the aim of which is to strengthen the self esteem of young people and to counter the spread of HIV/AIDS.

Read more

News from the Group: Camurus's initial public offering a success

On Thursday December 3, 2015, Camurus started its first day of trading on Nasdaq Stockholm. The share price increased considerably during the first day and Camurus is now the largest company in the biotechnology sector on Nasdaq Stockholm

Read more

News from the Group: Camurus to be listed on Nasdaq Stockholm

Camurus announces initial public offering on Nasdaq Stockholm. The company plans a new shares issue to a value of SEK 500 million net - a market capitalization of appr. SEK 2 billion.

Read more

News from Sandberg Development: Mazars company award 2015 to Sandberg Development

On November 3, 2015, Sandberg Development received Mazars prize for sustainable business. Per Sandberg was present at the prize ceremony which took place in Malmö.

Read more

News from Sandberg Development: New CFO at Sandberg Development

As of August 25, 2015 Kent Bengtsson started working as CFO in Sandberg Development.

Read more

News from the Group: Major GRANULDISK investment - inauguration of new production facility in Malmö

GRANULDISK recently moved into new facilities in Malmö. The history behind the large-scale investment is strong growth in Sweden and Europe and increased demand, not least from Asia and the Middle East. The company has recruited about ten new employees and expects to recruit more in the longer run.

Read more

News from Sandberg Development: GS Development changes its name to Sandberg Development AB

In the wake of an extensive branding process, GS Development is changing its name to Sandberg Development AB. This process was initiated to clarify its communications so that they reflect the group’s focus on world-class innovations.

Read more